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Summary
New national health information privacy standards have been issued by the U.S. Department of Health and Human Services
(DHHS), pursuant to the Health Insurance Portability and Accountability Act of 1996 (HIPAA). The new regulations provide
protection for the privacy of certain individually identifiable health data, referred to as protected health information (PHI).
Balancing the protection of individual health information with the need to protect public health, the Privacy Rule expressly
permits disclosures without individual authorization to public health authorities authorized by law to collect or receive the
information for the purpose of preventing or controlling disease, injury, or disability, including but not limited to public health
surveillance, investigation, and intervention.
Public health practice often requires the acquisition, use, and exchange of PHI to perform public health activities (e.g., public
health surveillance, program evaluation, terrorism preparedness, outbreak investigations, direct health services, and public health
research). Such information enables public health authorities to implement mandated activities (e.g., identifying, monitoring,
and responding to death, disease, and disability among populations) and accomplish public health objectives. Public health
authorities have a long history of respecting the confidentiality of PHI, and the majority of states as well as the federal government
have laws that govern the use of, and serve to protect, identifiable information collected by public health authorities.
The purpose of this report is to help public health agencies and others understand and interpret their responsibilities under the
Privacy Rule. Elsewhere, comprehensive DHHS guidance is located at the HIPAA website of the Office for Civil Rights (http://
www.hhs.gov/ocr/hipaa/).
Introduction
The shift of medical records from paper to electronic for-
mats has increased the potential for individuals to access, use,
and disclose sensitive personal health data. Although protect-
ing individual privacy is a long-standing tradition among
health-care providers and public health practitioners in the
United States, previous legal protections at the federal, tribal,
state, and local levels were inconsistent and inadequate. A
patchwork of laws provided narrow privacy protections for
selected health data and certain keepers of that data (1).
The U.S. Department of Health and Human Services
(DHHS) has addressed these concerns with new privacy stan-
dards that set a national minimum of basic protections, while
balancing individual needs with those of society. The Health
Insurance Portability and Accountability Act of 1996 (HIPAA)
was adopted to ensure health insurance coverage after leaving
an employer and also to provide standards for facilitating
health-care–related electronic transactions. To improve the
efficiency and effectiveness of the health-care system, HIPAA
included administrative simplification provisions that required
DHHS to adopt national standards for electronic health-care
transactions (2). At the same time, Congress recognized that
advances in electronic technology could erode the privacy of
health information. Consequently, Congress incorporated into
HIPAA provisions that mandated adoption of federal privacy
protections for certain individually identifiable health infor-
mation.
The HIPAA Privacy Rule (Standards for Privacy of Indi-
vidually Identifiable Health Information) (3) provides the first
national standards for protecting the privacy of health infor-
mation. The Privacy Rule regulates how certain entities, called
covered entities, use and disclose certain individually identifi-
able health information, called protected health information
(PHI). PHI is individually identifiable health information that
is transmitted or maintained in any form or medium (e.g.,
electronic, paper, or oral), but excludes certain educational
records and employment records. Among other provisions, the
Privacy Rule
• gives patients more control over their health information;
• sets boundaries on the use and release of health records;
• establishes appropriate safeguards that the majority of
health-care providers and others must achieve to protect
the privacy of health information;
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• holds violators accountable with civil and criminal penal-
ties that can be imposed if they violate patients’ privacy
rights;
• strikes a balance when public health responsibilities sup-
port disclosure of certain forms of data;
• enables patients to make informed choices based on how
individual health information may be used;
• enables patients to find out how their information may
be used and what disclosures of their information have
been made;
• generally limits release of information to the minimum
reasonably needed for the purpose of the disclosure;
• generally gives patients the right to obtain a copy of their
own health records and request corrections; and
• empowers individuals to control certain uses and disclo-
sures of their health information.
The deadline to comply with the Privacy Rule is April 14,
2003, for the majority of the three types of covered entities
specified by the rule [45 CFR § 160.102]. The covered enti-
ties are
• health plans,
• health-care clearinghouses, and
• health-care providers who transmit health information in
electronic form in connection with certain transactions.
At DHHS, the Office for Civil Rights (OCR) has oversight
and enforcement responsibilities for the Privacy Rule. Com-
prehensive guidance and OCR answers to hundreds of ques-
tions are available at http://www.hhs.gov/ocr/hipaa (4).
Impact on Public Health
Public health practice and research, including such tradi-
tional public health activities as program operations, public
health surveillance, program evaluation, terrorism prepared-
ness, outbreak investigations, direct health services, and pub-
lic health research, use PHI to identify, monitor, and respond
to disease, death, and disability among populations. Public
health authorities have a long history of protecting and pre-
serving the confidentiality of individually identifiable health
information. They also recognize the importance of protect-
ing individual privacy and respecting individual dignity to
maintaining the quality and integrity of health data. CDC
and others have worked to consistently strengthen federal and
state public health information privacy practices and legal pro-
tections (5).
DHHS recognized the importance of sharing PHI to
accomplish essential public health objectives and to meet cer-
tain other societal needs (e.g., administration of justice and
law enforcement). Therefore, the Privacy Rule expressly per-
mits PHI to be shared for specified public health purposes.
For example, covered entities may disclose PHI, without indi-
vidual authorization, to a public health authority legally
authorized to collect or receive the information for the pur-
pose of preventing or controlling disease, injury, or disability
[45 CFR § 164.512(b)] (Box 1). Further, the Privacy Rule
permits covered entities to make disclosures that are required
by other laws, including laws that require disclosures for pub-
lic health purposes.
Thus, the Privacy Rule provides for the continued func-
tioning of the U.S public health system. Covered entities should
become fully aware of the scope of permissible disclosures for
public health activities as well as state and local reporting laws
and regulations. Moreover, a public health authority may also
Without individual authorization, a covered entity may
disclose PHI to a public health authority* that is legally
authorized to collect or receive the information for the
purposes of preventing or controlling disease, injury, or
disability including, but not limited to
• reporting of disease, injury, and vital events (e.g., birth
or death); and
• conducting public health surveillance, investigations,
and interventions.
 PHI may also be disclosed without individual authori-
zation to
• report child abuse or neglect to a public health or other
government authority legally authorized to receive such
reports;
• a person subject to jurisdiction of the Food and Drug
Administration (FDA) concerning the quality, safety,
or effectiveness of an FDA-related product or activity
for which that person has responsibility;
• a person who may have been exposed to a communi-
cable disease or may be at risk for contracting or spread-
ing a disease or condition, when legally authorized to
notify the person as necessary to conduct a public
health intervention or investigation; and
• an individual’s employer, under certain circumstances
and conditions, as needed for the employer to meet
the requirements of the Occupational Safety and
Health Administration, Mine Safety and Health Ad-
ministration, or a similar state law.
Source: Adapted from [45 CFR § 164.512(b)].
* Or to an entity working under a grant of authority from a public health
authority, or when directed by a public health authority, to a foreign
government agency that is acting in collaboration with a public health
authority.
BOX 1. Protected health information (PHI) disclosures by
covered entities for public health activities requiring no
authorization under the Privacy Rule
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be a covered entity. For example, a public health agency that
operates a health clinic, providing essential health-care ser-
vices and performing covered transactions electronically, is a
covered entity.
This report provides guidance to public health authorities
and their authorized agents, researchers, and health-care pro-
viders in interpreting the Privacy Rule as it affects public health.
CDC recommends that public health authorities share the
information in this report with covered health-care providers
and other covered entities and work closely with those entities
to ensure implementation of the rule consistent with its
intent to protect privacy while permitting authorized public
health activities to continue.
Overview of the Privacy Rule
Who Is Covered
The authority of DHHS to issue health-information pri-
vacy regulations was limited by Congress in HIPAA to a
defined set of covered entities. More complete definitions of
these, and other terms, are located elsewhere in this report
(Appendix A). Covered entities are as follows:
• Health plans. An individual or group plan that provides,
or pays the cost of, medical care that includes the diagno-
sis, cure, mitigation, treatment, or prevention of disease.
Health plans include private entities (e.g., health insurers
and managed care organizations) and government orga-
nizations (e.g., Medicaid, Medicare, and the Veterans
Health Administration).
• Health-care clearinghouses. A public or private entity,
including a billing service, repricing company, or com-
munity health information system, that processes non-
standard data or transactions received from another entity
into standard transactions or data elements, or vice versa.
• Health-care providers. A provider of health-care services
and any other person or organization that furnishes, bills,
or is paid for health care in the normal course of business.
Health-care providers (e.g., physicians, hospitals, and clin-
ics) are covered entities if they transmit health informa-
tion in electronic form in connection with a transaction
for which a HIPAA standard has been adopted by DHHS.
The Privacy Rule also establishes requirements for covered
entities with regard to their nonemployee business associates
(e.g., lawyers, accountants, billing companies, and other con-
tractors) whose relationship with covered entities requires shar-
ing of PHI. The Privacy Rule allows a covered provider or
health plan to disclose PHI to a business associate if satisfac-
tory written assurance is obtained that the business associate
will use the information only for the purposes for which it
was engaged, will safeguard the information from misuse, and
will help the covered entity comply with certain of its duties
under the Privacy Rule.
The Privacy Rule does not apply to all persons or entities
that regularly use, disclose, or store individually identifiable
health information. For example, the Privacy Rule does not
cover employers, certain insurers (e.g., auto, life, and worker
compensation), or those public agencies that deliver social
security or welfare benefits, when functioning solely in these
capacities.
Types of Health Information
Protected Health Information
 The Privacy Rule protects certain information that covered
entities use and disclose. This information is called protected
health information (PHI), which is generally individually iden-
tifiable health information that is transmitted by, or main-
tained in, electronic media or any other form or medium. This
information must relate to 1) the past, present, or future physi-
cal or mental health, or condition of an individual; 2) provi-
sion of health care to an individual; or 3) payment for the
provision of health care to an individual. If the information
identifies or provides a reasonable basis to believe it can be
used to identify an individual, it is considered individually
identifiable health information.
De-Identified Information
De-identified data (e.g., aggregate statistical data or data
stripped of individual identifiers) require no individual pri-
vacy protections and are not covered by the Privacy Rule.
De-identifying can be conducted through
• statistical de-identification — a properly qualified statis-
tician using accepted analytic techniques concludes the
risk is substantially limited that the information might be
used, alone or in combination with other reasonably avail-
able information, to identify the subject of the informa-
tion [45 CFR § 164.514(b)]; or the
• safe-harbor method — a covered entity or its business
associate de-identifies information by removing 18 iden-
tifiers (Box 2) and the covered entity does not have actual
knowledge that the remaining information can be used
alone or in combination with other data to identify the
subject [45 CFR § 164.514(b)].
In certain instances, working with de-identified data may have
limited value to clinical research and other activities. When
that is the case, a limited data set may be useful.
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The following protected health information (PHI) can
be included, without authorization, in a limited data set
for public health, research, or health-care operations:
• town or city, state, and zip code; and
• elements of dates related to a person (e.g., years, birth
dates, admission dates, discharge dates, and dates of
death).
To disclose a limited data set, a covered entity must en-
ter into a data-use agreement with the recipient, which
agrees to use or disclose the PHI for limited purposes.
Disclosure of a limited data set is not subject to the ac-
counting requirement, but must meet the minimum nec-
essary standards of the Privacy Rule.
BOX 3. Use of limited data sets under the Privacy Rule
The following 18 identifiers of a person, or of relatives,
employers, or household members of a person must be
removed, and the covered entity must not have actual
knowledge that the information could be used alone or in
combination with other information to identify the indi-
vidual, for the information to be considered de-identified
and not protected health information (PHI):
• names;
• all geographic subdivisions smaller than a state, in-
cluding county, city, street address, precinct, zip code,*
and their equivalent geocodes;
• all elements of dates (except year) directly related to
an individual; all ages >89 and all elements of dates
(including year) indicative of such age (except for an
aggregate into a single category of age >90);
• telephone numbers;
• fax numbers;
• electronic mail addresses;
• Social Security numbers;
• medical record numbers;
• health-plan beneficiary numbers;
• account numbers;
• certificate and license numbers;
• vehicle identifiers and serial numbers, including
license plate numbers;
• medical device identifiers and serial numbers;
• Internet universal resource locators (URLs);
• Internet protocol (IP) addresses;
• biometric identifiers including fingerprints and voice
prints;
• full-face photographic images and any comparable
images; and
• any other unique identifying number, characteristic,
or code, except that covered identities may, under cer-
tain circumstances, assign a code or other means of
record identification that allows de-identified infor-
mation to be re-identified.
Source: Adapted from [45 CFR § 164.514(b)(2)(i)].
* The first three digits of a zip code are excluded from the PHI list if the
geographic unit formed by combining all zip codes with the same first
three digits contains >20,000 persons.
BOX 2. Individual identifiers under the Privacy Rule
permitted to use or receive the limited data set, and provide
that the recipient will
• not use or disclose the information other than as permit-
ted by the agreement or as otherwise required by law;
• use appropriate safeguards to prevent uses or disclosures
of the information that are inconsistent with the data-use
agreement;
• report to the covered entity any use or disclosure of the
information, in violation of the agreement, of which it
becomes aware;
• ensure that any agents to whom it provides the limited
data set agree to the same restrictions and conditions that
apply to the limited data set recipient with respect to such
information; and
• not attempt to re-identify the information or contact the
individual.
What is Required
For covered entities using or disclosing PHI, the Privacy
Rule establishes a range of health-information privacy require-
ments and standards that attempt to balance individual pri-
vacy interests with the community need to use such data [45
CFR § 164.504]. Among its provisions, the Privacy Rule
requires covered entities to
• notify individuals regarding their privacy rights and how
their PHI is used or disclosed;
• adopt and implement internal privacy policies and proce-
dures;
• train employees to understand these privacy policies and
procedures as appropriate for their functions within the
covered entity;
Limited Data Sets
 Health information in a limited data set is not directly iden-
tifiable, but may contain more identifiers than de-identified
data that has been stripped of the 18 identifiers [45 CFR §
164.514] (Box 3). A data-use agreement must establish who is
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• designate individuals who are responsible for implement-
ing privacy policies and procedures, and who will receive
privacy-related complaints;
• establish privacy requirements in contracts with business
associates that perform covered functions;
• have in place appropriate administrative, technical, and
physical safeguards to protect the privacy of health infor-
mation; and
• meet obligations with respect to health consumers exer-
cising their rights under the Privacy Rule.
With respect to individuals, they are vested with the follow-
ing rights:
• Receive access to PHI. Individual rights include inspec-
tions of records and the provision for copies of PHI about
the individual in a designated record set, for as long as the
PHI is maintained in the designated record set, except for
psychotherapy notes, information complied for use in civil,
criminal, or administrative actions, and PHI maintained
by a covered entity subject to the Clinical Laboratory
Improvement Amendments of 1988 [42 CFR § 263(a)].
In the majority of cases, covered entities must accommo-
date a request or provide a process of denial, subject to
review [45 CFR § 164.524].
• Request amendments to PHI. Individuals can request that
covered entities amend PHI about the individual in a des-
ignated record set for as long as the PHI is maintained in
a designated record set. If the covered entity agrees to the
amendment, it must 1) identify the records affected; 2)
append or provide a link to the amendment; 3) inform
the individual the amendment has been made; and 4) work
with other covered entities or business associates who pos-
sess or receive the data to make the amendments [45 CFR
§ 164.526]. If the covered entity denies this request, the
Privacy Rule provides a process for contesting the denial
[45 CFR § 164.526].
• Receive adequate notice. With limited exceptions, indi-
viduals have the right to receive a notice of the uses and
disclosures the covered entity will make of their PHI, their
rights under the Privacy Rule, and the covered entity’s
obligations with respect to that information. In certain
cases, notice may be provided electronically. The notice
must be in plain language (e.g., “your health information
may be shared with public health authorities for public
health purposes . . .” ) and posted where it is likely to be
seen by patients [45 CFR § 164.520].
• Receive an accounting of disclosures. Upon request, cov-
ered entities are required to provide individuals with an
accounting for certain types of disclosures of PHI,
although the rule contains certain exceptions, including
disclosures with individual authorization, disclosures
related to providers’ treatment, payment and health-care
operations (TPO), and other exceptions. A typical a
ccounting includes the name of the person or entity who
received the information, date of the disclosure, a brief
description of the information disclosed, and a brief e
xplanation of the reasons for disclosure or copy of the
request [45 CFR § 164.528]. However, requirements for
accounting of public health disclosures may vary (see
Accounting for Public Health Disclosures).
• Request restrictions. Individuals have the right to request
a restriction on certain uses or disclosures of their PHI;
however, the covered entity is not obligated to agree to
such a request. If the covered entity does agree to a restric-
tion, it must generally abide by the agreement, except for
emergency treatment situations. But such an agreement is
not effective to prevent certain permitted uses or disclo-
sures [CFR 45 § 164.512].
Required PHI Disclosures
A covered entity is required by the Privacy Rule to disclose
PHI in only two instances: 1) when an individual has a right
to access an accounting of his or her PHI (see previous para-
graph); and 2) when DHHS needs PHI to determine compli-
ance with the Privacy Rule [45 CFR § 164.502(a)(2)]. Certain
other uses and disclosures of PHI may be permitted without
authorization, but are not required by the Privacy Rule. How-
ever, other federal, tribal, state, or local laws may compel dis-
closure.
Permitted PHI Disclosures Without
Authorization
The Privacy Rule permits a covered entity to use and dis-
close PHI, with certain limits and protections, for TPO
activities [45 CFR § 164.506]. Certain other permitted uses
and disclosures for which authorization is not required fol-
low. Additional requirements and conditions apply to these
disclosures. The Privacy Rule text and OCR guidance should
be consulted for a full understanding of the following:
• Required by law. Disclosures of PHI are permitted when
required by other laws, whether federal, tribal, state, or
local.
• Public health. PHI can be disclosed to public health
authorities and their authorized agents for public health
purposes including but not limited to public health sur-
veillance, investigations, and interventions.
• Health research. A covered entity can use or disclose PHI
for research without authorization under certain condi-
tions, including 1) if it obtains documentation of a waiver
from an institutional review board (IRB) or a privacy
board, according to a series of considerations; 2) for
6 MMWR May 2, 2003
activities preparatory to research; and 3) for research on a
decedent’s information.
• Abuse, neglect, or domestic violence. PHI may be dis-
closed to report abuse, neglect, or domestic violence
under specified circumstances.
• Law enforcement. Covered entities may, under specified
conditions, disclose PHI to law enforcement officials pur-
suant to a court order, subpoena, or other legal order, to
help identify and locate a suspect, fugitive, or missing
person; to provide information related to a victim of a
crime or a death that may have resulted from a crime, or
to report a crime.
• Judicial and administrative proceedings. A covered entity
may disclose PHI in the course of a judicial or adminis-
trative proceeding under specified circumstances.
• Cadaveric organ, eye, or tissue donation purposes.
Organ-procurement agencies may use PHI for the pur-
poses of facilitating transplant.
• Oversight. Covered entities may usually disclose PHI to a
health oversight agency for oversight activities authorized
by law.
• Worker’s compensation. The Privacy Rule permits dis-
closure of work-related health information as authorized
by, and to the extent necessary to comply with, workers’
compensation programs.
Other Authorized Disclosures
 A valid authorization is required for any use or disclosure
of PHI that is not required or otherwise permitted without
authorization by the Privacy Rule. In general, these authoriza-
tions must
• specifically identify the PHI to be used or disclosed;
• provide the names of persons or organizations, or classes
of persons or organizations, who will receive, use, or dis-
close the PHI;
• state the purpose for each request;
• notify individuals of their right to refuse to sign the
authorization without negative consequences to treatment,
payment, or health plan enrollment or benefit eligibility,
except under specific circumstances;
• be signed and dated by the individual or the individual’s
personal representative;
• be written in plain language;
• include an expiration date or event;
• notify the individual of the right to revoke authorization
at any time in writing, and how to exercise that right, and
any applicable exceptions to that right under the Privacy
Rule; and
• explain the potential for the information to be subject to
redisclosure by recipient and no longer protected by the
Privacy Rule.
The Privacy Rule and Public Health
 The Privacy Rule recognizes 1) the legitimate need for pub-
lic health authorities and others responsible for ensuring the
public’s health and safety to have access to PHI to conduct
their missions; and 2) the importance of public health report-
ing by covered entities to identify threats to the public and
individuals. Accordingly, the rule 1) permits PHI disclosures
without a written patient authorization for specified public
health purposes to public health authorities legally authorized
to collect and receive the information for such purposes, and
2) permits disclosures that are required by state and local pub-
lic health or other laws. However, because the Privacy Rule
affects the traditional ways PHI is used and exchanged among
covered entities (e.g., doctors, hospitals, and health insurers),
it can affect public health practice and research in multiple
ways. To prevent misconceptions, understanding the Privacy
Rule is important for public health practice. Some illustrative
examples are presented in this report (Box 4). Also provided
are sample letters that might prove useful in clarifying rela-
tionships involving public health and the Privacy Rule
(Appendix B).
A public health authority is broadly defined as including
agencies or authorities of the United States, states, territories,
political subdivisions of states or territories, American Indian
tribes, or an individual or entity acting under a grant of
authority from such agencies and responsible for public health
matters as part of an official mandate. Public health authori-
ties include federal public health agencies (e.g., CDC,
National Institutes of Health [NIH], Health Resources and
Services Administration [HRSA], Substance Abuse and Men-
tal Health Services Administration [SAMHSA], Food and
Drug Administration [FDA], or Occupational Safety and
Health Administration [OSHA]); tribal health agencies; state
public health agencies (e.g., public health departments or
divisions, state cancer registries, and vital statistics depart-
ments); local public health agencies; and anyone performing
public health functions under a grant of authority from a public
health agency [45 CFR § 164.501].
Public health agencies often conduct their authorized pub-
lic health activities with other entities by using different mecha-
nisms (e.g., contracts and memoranda or letters of agreement).
These other entities are public health authorities under the
Privacy Rule with respect to the activities they conduct under
a grant of authority from such a public health agency. A
covered entity may disclose PHI to public health authorities
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State cancer registry. Under a state law, health-care provid-
ers are required to report cancer cases to a state’s cancer regis-
try. Names are included to prevent duplicate reporting and
counting. State law protects the confidentiality of the data.
Can covered entities disclose the information under the Pri-
vacy Rule?
Privacy Rule effect. Covered entities may disclose PHI to a
public health agency, or any other entity, when the disclosure
is required by law. However, as covered entities, the providers
must give an accounting to the persons whose PHI has been
shared. The state agency may use and further disclose the PHI
consistent with applicable state law.
State university-maintained cancer registry. Under a state
law, health-care providers are mandated to report cancer cases
to a state health department’s cancer registry. The state health
department contracts with a state university to receive the
reports and maintain its registry. As covered entities, can health-
care providers disclose PHI to the state university under the
Privacy Rule?
Privacy Rule effect. As noted in the previous example, cov-
ered entities may disclose, without authorization, PHI to the
cancer registry under the Privacy Rule, which expressly per-
mits disclosure of PHI as required by law and sharing of PHI
with public health authorities for public health purposes. The
state university is acting under a grant of authority from a public
health authority, the state health department. The university
can use and disclose the information, without authorization,
consistent with its agreement with the state health department
and applicable state law.
Early hearing detection and intervention. An early hear-
ing detection and intervention program in a state needs data
from two large hospitals. The state does not have a law requir-
ing reporting of hearing loss. Under the Privacy Rule, can cov-
ered entities release results of newborn hearing-screening tests
to the state program?
Privacy Rule effect. The Privacy Rule expressly permits
release of PHI, without authorization, from a covered entity
to a public health authority (e.g., the state health department),
which is authorized by law to receive PHI for the purpose of
BOX 4. Examples of situations related to the Privacy Rule and public health
controlling disease, injury, or disability. The rule does not
require a state law mandating such disclosures for PHI to be
released to a public health authority. Finally, the covered
entities may rely upon the state’s representation that the
information requested is the minimum necessary for the pur-
poses of the registry.
Disease registry maintained by private foundation. A
private foundation maintains a disease registry as a way to
support research and service for those with the disease. Can
health-care providers release PHI to the foundation under
the Privacy Rule?
Privacy Rule effect. Nongovernment disease registries (e.g.,
those maintained by foundations and other private organiza-
tions) are not considered public health authorities unless they
have a grant of authority from a public health authority. With
such a grant, covered entities may disclose PHI to the foun-
dations. But without a grant of authority, PHI may be
released only under one of the following situations:
• Release is authorized by the patient.
• The PHI is de-identified.
• The PHI is contained in a limited data set governed by
a data-use agreement.
• Release of PHI is in accord with the rule’s provisions
for disclosure for research without authorization.
• Release is otherwise permitted by the rule (e.g., to
entities subject to the jurisdiction of the Food and Drug
Administration (FDA) [45 CFR § 164.512(b)(1)(iii)].
Surveillance project. A state health department that is not
a covered entity conducts a surveillance project on human
immunodeficiency virus (HIV) and acquired immunodefi-
ciency syndrome (AIDS). The HIV/AIDS surveillance project
is an interview study. It asks for self-reported information
from participants, including dates of diagnosis and visits for
care. Is this PHI covered by the Privacy Rule?
Privacy Rule effect. Information collected directly from
persons by a person, agency, or institution that is not a cov-
ered entity, including individually identifiable information,
is not covered by the Privacy Rule.
and to these designated entities pursuant to the public health
provisions of the Privacy Rule.
The Privacy Rule permits covered entities to disclose PHI,
without authorization, to public health authorities or other
entities who are legally authorized to receive such reports for
the purpose of preventing or controlling disease, injury, or
disability. This includes the reporting of disease or injury;
reporting vital events (e.g., births or deaths); conducting pub-
lic health surveillance, investigations, or interventions; report-
ing child abuse and neglect; and monitoring adverse outcomes
related to food (including dietary supplements), drugs, bio-
logical products, and medical devices [45 CFR 164.512(b)].
Covered entities may report adverse events related to FDA-
regulated products or activities to public agencies and private
entities that are subject to FDA jurisdiction [45 CFR
164.512(b)(1)(iii)]. To protect the health of the public, pub-
lic health authorities might need to obtain information
related to the individuals affected by a disease. In certain cases,
they might need to contact those affected to determine the
cause of the disease to allow for actions to prevent further
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illness. Also, covered entities may, at the direction of a public
health authority, disclose protected health information to a
foreign government agency that is acting in collaboration with
a public health authority [45 CFR 164.512(b)(1)(i)].
To receive PHI for public health purposes, public health
authorities should be prepared to verify their status and iden-
tity as public health authorities under the Privacy Rule. To
verify its identity, an agency could provide any one of the fol-
lowing:
• if the request is made in person, presentation of an agency
identification badge, other official credentials, or other
proof of government status;
• if the request is in writing, the request is on the appropri-
ate government letterhead;
• if the disclosure is to a person acting on behalf of a public
health authority, a written statement on appropriate gov-
ernment letterhead that the person is acting under the
government’s authority [45 CFR § 164.514(h)(2)].
Public health authorities receiving information from covered
entities as required or authorized by law [45 CFR 164.512(a)]
[45 CFR 164.512(b)] are not business associates of the cov-
ered entities and therefore are not required to enter into busi-
ness associate agreements. Public health authorities that are
not covered entities also are not required to enter into busi-
ness associate agreements with their public health partners and
contractors. Also, after PHI is disclosed to a public health
authority pursuant to the Privacy Rule, the public health
authority (if it is not a covered entity) may maintain, use, and
disclose the data consistent with the laws, regulations, and
policies applicable to the public health authority.
Disclosures for Public Health Purposes
The Privacy Rule allows covered entities to disclose PHI to
public health authorities when required by federal, tribal, state,
or local laws [45 CFR 164.512(a)]. This includes state laws
(or state procedures established under such law) that provide
for receiving reporting of disease or injury, child abuse, birth,
or death, or conducting public health surveillance, investiga-
tion, or intervention.
For disclosures not required by law, covered entities may
still disclose, without authorization, to a public health authority
authorized by law to collect or receive the information for the
purpose of preventing or controlling disease, injury, or dis-
ability, the minimum necessary information to accomplish the
intended public health purpose of the disclosure [45 CFR
164.512 (b)] (Box 1).
For example, to protect the health of the public, public health
officials might need to obtain information related to persons
affected by a disease. In certain cases, they might need to con-
tact those affected to determine the cause of the disease to
allow for actions to prevent further illness. The Privacy Rule
continues to allow for the existing practice of sharing PHI
with public health authorities who are authorized by law to
collect or receive such information to aid them in their mis-
sion of protecting the health of the public. Examples of such
activities include those directed at the reporting of disease or
injury, reporting adverse events, reporting births and deaths,
and investigating the occurrence and cause of injury and dis-
ease (1).
Although it is not a defined term, DHHS interpreted the
phrase “authorized by law” to mean that a legal basis exists for
the activity. Further, DHHS called the phrase “a term of art,”
including both actions that are permitted and actions that are
required by law [64 FR 59929, November 3, 1999]. This does
not mean a public health authority at the federal, tribal, state,
or local level must have multiple disease or condition-specific
laws that authorize each collection of information. Public
health authorities operate under broad mandates to protect
the health of their constituent populations.
Requirements for Covered Entities
Accounting for Public Health Disclosures
Although the Privacy Rule permits disclosures of PHI to
public health authorities, covered entities must comply with
certain requirements related to these disclosures. One such
requirement is that a covered entity must be able to provide
an individual, upon request, with an accounting of certain
disclosures of PHI. The covered entity is not required to
account for all disclosures of PHI. For example, an account-
ing is not required for disclosures made
• prior to the covered entity’s compliance date;
• for TPO purposes;
• to the individual or pursuant to the individual’s written
authorization; or
• as part of a limited data set.
However, usually an accounting is required for disclosures
made without authorization, including public health purposes.
The required accounting for disclosures may be
accomplished in different ways. Typically, the covered entity
must provide the individual with an accounting of each
disclosure by date, the PHI disclosed, the identity of the
recipient of the PHI, and the purpose of the disclosure.
However, where the covered entity has, during the accounting
period, made multiple disclosures to the same recipient for
the same purpose, the Privacy Rule provides for a simplified
means of accounting. In such cases, the covered entity need
only identify the recipient of such repetitive disclosures, the
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purpose of the disclosure, and describe the PHI routinely
disclosed. The date of each disclosure need not be tracked.
Rather, the accounting may include the date of the first and
last such disclosure during the accounting period, and a
description of the frequency or periodicity of such disclosures.
For example, the vast amount of data exchanged between
covered entities and public health authorities is made through
ongoing, regular reporting or inspection requirements. A
covered health-care provider may routinely report all cases of
measles it diagnoses to the local public health authority. An
accounting of such disclosures to a requesting individual would
need to identify the local public health authority receiving
the PHI, the PHI disclosed, the purpose of the disclosure
(required for communicable disease surveillance), the
periodicity (weekly), and the first and last dates of such
disclosures during the accounting period (May 1, 2003 to
June 1, 2003). Thus, the covered entity would not need to
annotate each patient’s medical record whenever a routine
public health disclosure was made.
Notice of Privacy Practices
 With certain exceptions, under the Privacy Rule, individu-
als have the right to adequate notice of the uses and disclo-
sures of PHI that may be made by the covered entity, as well as
their rights and the covered entity’s legal obligations. Notices
must be in plain language and clearly posted. Certain covered
entities must make a good faith effort to obtain an individual’s
acknowledgment of receipt of this notice. In certain cases,
notice may be provided electronically.
Minimum Necessary Standard
The Privacy Rule usually directs covered entities to limit
the amount of information disclosed to the minimum neces-
sary to achieve the specified goal [45 CFR § 164.514(d)(1)].
This requirement usually applies to disclosures to a public
health agency. It would not apply, however, if the disclosure
were required by law, authorized by the individual, or for treat-
ment purposes. A covered entity may also reasonably rely on a
public official’s determination that the information requested
is the minimum necessary for the public health purpose.
Public Health Authorities Performing Covered
Functions
Public health authorities at the federal, tribal, state, or local
levels that perform covered functions (e.g., providing health
care or insuring individuals for health-care costs), may be sub-
ject to the Privacy Rule’s provisions as covered entities. For
example, a local public health authority that operates a health
clinic providing essential health-care services to low-income
persons and performs certain electronic transactions might be
defined under the Privacy Rule as a covered health-care pro-
vider and therefore a covered entity. Flow charts and interac-
tive tools designed to help determine covered entity status are
provided online by the Centers for Medicare and Medicaid
Services, available at http://www.cms.gov/hipaa/hipaa2/sup-
port/tools/decisionsupport/default.asp.
The following are examples of public health authority func-
tions that make them covered entities:
• Public health authorities as covered health-care pro-
viders. A public health authority that conducts health care
as part of its activities is a covered health-care provider if
it also performs electronic transactions covered by the
HIPAA Transactions Rule as part of these activities. The
fact that these activities are conducted in pursuit of a public
health goal (e.g., vaccinating children or screening a tar-
geted population for sexually transmitted diseases) does
not preclude the public health authority from being a cov-
ered entity.
• Public health authorities as health plans. Under the
Privacy Rule, a health plan is an individual or group plan
that provides, or pays the cost of, medical care. This spe-
cifically includes government health plans (e.g., Medicare,
Medicaid, or Veterans Health Administration). However,
the Privacy Rule defines health plan to exclude govern-
ment-funded programs whose principal activity is the di-
rect provision of health care to persons or the making of
grants to fund the direct provision of health care to per-
sons [45 CFR § 160.103]. Examples include the Ryan
White Comprehensive AIDS Resources Emergency Act.
Although certain government programs that fund provid-
ers directly may not be health plans, government programs
that reimburse providers or otherwise fund providers to
perform direct health-care services should carefully ana-
lyze the details of their programs to determine if they are
performing covered functions.
• Public health authorities as health-care clearinghouses.
Although unlikely, a public health authority might be a
health-care clearinghouse if it receives health information
from another entity and translates that information from
a nonstandard format into a standard transaction or stan-
dard data elements (or vice versa). Operators of commu-
nity health information systems should carefully consider
whether they meet the definition for a health-care clear-
inghouse.
• Public health agencies as hybrid entities. A public health
agency that is a covered entity, and has both covered and
noncovered functions may become a hybrid entity by des-
ignating its health-care components. By designating itself
as a hybrid entity, a public health authority can carve out
its noncovered functions, so that the majority of Privacy
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Rule provisions apply only to its health-care component,
which is required to comply with the Privacy Rule
requirements, including using and disclosing PHI only as
authorized, meeting the administrative requirements,
accounting for disclosure of PHI, and providing a notice
of practices. However, such a designation does not pre-
clude the public health authority from continuing to con-
duct authorized public health functions. A covered entity
that is also a public health authority may use, as well as
disclose, PHI for public health purposes to the same
extent it would be permitted to disclose the PHI as a pub-
lic health authority.
The Privacy Rule and Public
Health Research
The topic of research under the Privacy Rule is covered in
depth in the DHHS report, Protecting Personal Health Infor-
mation in Research — Understanding the HIPAA Privacy Rule
(6). The Privacy Rule provides separate provisions for disclo-
sure without individual authorization for public health pur-
poses and for certain research [45 CFR § 164.512(b)] [45
CFR  § 164.512(i)]. Other federal law pertaining to research
stresses the importance of distinguishing between research and
practice to ensure that human subjects are appropriately pro-
tected [45 CFR Part 46]. For certain activities, this distinc-
tion is not always clear. A full discussion of the distinctions
between public health practice and research is beyond the scope
of this document. However, CDC and others provide guid-
ance in this area (7–9).
Research Versus Practice
The definition of research is the same for the Privacy Rule
and the Common Rule (10) — systematic investigation,
including research development, testing, and evaluation,
designed to develop or contribute to generalizable knowledge.
Research is designed to test a hypothesis, permit conclusions
to be drawn, and thereby to develop or contribute to general-
izable knowledge. The majority of public health activities (e.g.,
public health surveillance, and disease prevention and control
projects) are based on scientific evidence and data collection
or analytic methods similar to those used in research. How-
ever, they are not designed to contribute to generalizable knowl-
edge. Their primary purpose is to protect the health of the
population through such activities as disease surveillance, pre-
vention, or control.
The Belmont Report (11) defines practice as interventions
designed solely to enhance the well-being of a person, patient,
or client, and which have reasonable expectation of success.
The report further states that the purpose of medical or
behavioral practice is to provide diagnosis, preventive treat-
ment, or therapy to particular patients. For public health agen-
cies, the patient is the community. Public health practice
activities (e.g., public health surveillance, disease control, or
program evaluation) are undertaken with the intent to benefit
a specific community, although occasionally they may pro-
vide unintended generalizable benefits to others.
Some public health activities that are initially public health
practice may subsequently evolve into a research activity (e.g.,
an investigation to determine the cause of an outbreak that
incorporates a research study evaluating the efficacy of a new
drug to treat the illness). When that is the case, the disclosures
may be made initially under the public health provisions of
the Privacy Rule. But when the activity becomes an ongoing
research activity, the entity should consider application of the
relevant research disclosures provisions to continue to obtain
information for this purpose. Moreover, there may be cases
where the activity is both research and public health practice
(e.g., an ongoing survey to monitor health conditions in the
population, data from which can also be analyzed for research
purposes). In those cases, disclosures may be made either un-
der the research provisions or the public health provisions, as
appropriate — the covered entity need not comply with both
sets of requirements.
The Privacy Rule and Other Laws
• Federal laws. Covered entities subject to the Privacy Rule
are also subject to other federal statutes and regulations.
The specific relationship of the Privacy Rule and certain
federal laws is discussed in the preamble to the December
2000 Final Rule [65 Fed.Reg. 82481]. In certain instances,
the Privacy Rule imposes requirements in direct conflict
with other federal laws or regulations. In those instances,
an analysis will be necessary to determine whether the later
provision was intended to overrule the prior law or regu-
lation.
• State laws. As a federal regulatory standard, the Privacy
Rule preempts only those contrary state laws relating to
the privacy of individually identifiable health informa-
tion that have less stringent requirements or standards than
the Privacy Rule (i.e., more stringent laws remain in
effect). In addition, DHHS may, upon specific request
from a state or other entity or person, determine that a
provision of state law that is contrary to the federal
requirements and that meets certain additional criteria,
will not be preempted by the federal requirements. Thus,
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preemption of a contrary state law will not occur if the
Secretary or designated DHHS official determines, in
response to a request, that the state law 1) is necessary to
prevent fraud and abuse related to the provision of or pay-
ment for health care; 2) is necessary to ensure appropriate
state regulation of insurance and health plans to the
extent expressly authorized by statute or regulation; 3) is
necessary for state reporting on health-care delivery or
costs; 4) is necessary to serve a compelling public health,
safety, or welfare need, and, if a Privacy Rule provision is
at issue, if the Secretary determines that the intrusion into
privacy is warranted when balanced against the need to be
served; or 5) has as its principal purpose the regulation of
the manufacture, registration, distribution, dispensing, or
other control of any controlled substances. The Privacy
Rule specifically does not preempt contrary state public
health laws that provide for the reporting of disease or
injury, child abuse, birth or death, or for the conduct of
public health surveillance, investigation, or intervention
[45 CFR § 160.202].
Online Resources
References to non-DHHS sites on the Internet are provided
as a service to MMWR readers and do not constitute or imply
endorsement of these organizations or their programs by CDC
or the U.S. Department of Health and Human Services. CDC
is not responsible for the content of these sites. URL addresses
listed in MMWR were current as of the date of publication.
Federal Government Resources
DHHS Office for Civil Rights — HIPAA guidelines
http://www.hhs.gov/ocr/hipaa
CDC — Privacy Rule guidelines
http://www.cdc.gov/privacyrule




Health Resources and Services Administration — HIPAA
http://www.hrsa.gov/website.htm
National Center for Health Statistics
http://www.cdc.gov/nchs/otheract/phdsc/phdsc.htm
National Committee on Vital and Health Statistics
http://www.ncvhs.hhs.gov/
National Health Information Infrastructure
http://www.health.gov/ncvhs-nhii/
Indian Health Service — HIPAA
http://www.ihs.gov/AdminMngrResources/HIPAA/index.cfm
National Institutes of Health
http://privacyruleandresearch.nih.gov
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Associations, Nonprofit Organizations,
and Academic Resources
American Hospital Association — HIPAA
http://www.hospitalconnect.com/aha/key_issues/hipaa/
resources/resources.html
American Medical Association — HIPAA
http://www.ama-assn.org/ama/pub/category/4234.html
Association of State and Territorial Health Officials —
HIPAA
http://www.astho.org/?template=hipaa.html
Georgetown University Health Privacy Project
http://www.healthprivacy.org/
Joint Healthcare Information Technology Alliance
http://www.jhita.org/
National Association of Health Data Organizations
http://www.nahdo.org/
National Association of Insurance Commissioners
http://www.naic.org/1privacy/initiatives/health_privacy.htm
National Governors Association — HIPAA
http://www.nga.org/center/topics/1,1188,C_CENTER_
ISSUE^D_4324,00.html
North Carolina Healthcare Information and Communica-
tions Alliance
http://www.nchica.org/
Public Health Grand Rounds HIPAA Privacy Rule:
Enhancing or Harming Public Health?
http://www.publichealthgrandrounds.unc.edu/
Stanford University Medical School — HIPAA
http://www.med.stanford.edu/HIPAA/
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The following concepts and definitions are adapted from
the regulatory language. For further information, see the cita-
tions to the Privacy Rule.
Accounting. An individual has a right to receive an account-
ing of disclosures of protected health information made by a
covered entity in the six years prior to the date on which the
accounting is requested, except for disclosures (a) to carry out
treatment, payment and health care operations [45 CFR §
164.506]; (b) to individuals of protected health information
about them [45 CFR § 164.502]; (c) incident to a use or dis-
closure otherwise permitted or required by this subpart, as
provided in 45 CFR §164.502; (d) pursuant to an authoriza-
tion as provided in 45 CFR §164.508; (e) for the facility’s
directory or to persons involved in the individual’s care or
other notification purposes, as provided in 45 CFR §164.510;
(f ) for national security or intelligence purposes as provided
in 45 CFR §164.512(k)(2), (g) to correctional institutions or
law enforcement officials as provided in 45 CFR §164.512
(k)(5); or (h) as part of a limited data set in accordance with
45 CFR §164.514(e); or (i) that occurred prior to the compli-
ance date for the covered entity…. Such an accounting must
meet the following requirements: (1) except as otherwise pro-
vided by paragraph (a) of this section, the accounting must
include disclosures of protected health information that
occurred during the six years (or such shorter time period at
the request of the individual as provided in paragraph (a)(3)
of this section) prior to the date of the request for an account-
ing, including disclosures to or by business associates of the
covered entity; (2) except as otherwise provided by paragraphs
(b)(3) or (b)(4) of this section, the accounting must include
for each disclosure: the date of the disclosure, the name of the
entity or person who received the protected health informa-
tion, and if known, the address of such entity or person; a
brief description of the protected health information disclosed;
and, a brief statement of the purpose of the disclosure that
reasonably informs the individual of the basis for the disclo-
sure, or in lieu of such a statement, a copy of the individual’s
written authorization pursuant to 45 CFR § 164.508, or a
copy of a written request for a disclosure under 45 CFR §
164.502(a)(2)(ii) or 45  CFR § 164.512, if any.
If, during the period covered by the accounting, the covered
entity has made multiple disclosures of protected health
information to the same person or entity for a single purpose
under 45 CFR § 164.502(a)(2)(ii) or 45 CFR § 164.512, the
accounting may, with respect to such multiple disclosures,
provide the information required by paragraph (b)(2) of 45
CFR § 164.528 for the first disclosure during the accounting
period, the frequency, periodicity, or number of the disclo-
sures made during the accounting period, and the date of the
last such disclosure during the accounting period [45 CFR §
164.528].
Modified accounting procedures are also provided for cov-
ered entities making research disclosures involving >50 per-
sons [45 CFR § 164.528(b)(4)].
Business associate. A person who, on behalf of a covered
entity or of an organized health care arrangement [45 CFR §
154.501] in which the covered entity participates, but other
than in the capacity of a member of the workforce of such
covered entity or arrangement, performs, or assists in the per-
formance of . . . a function or activity involving the use or
disclosure of individually identifiable health information,
including claims processing or administration, data analysis,
processing or administration, utilization review, quality assur-
ance, billing, benefit management, practice management, and
repricing; or any other function or activity regulated by this
subchapter; or provides, other than in the capacity of a mem-
ber of the workforce of such covered entity, legal, actuarial,
accounting, consulting, data aggregation [45 CFR § 164.501],
management, administrative, accreditation, or financial ser-
vices to or for such covered entity, or to or for an organized
health-care arrangement in which the covered entity partici-
pates, where the provision of the service involves the disclo-
sure of individually identifiable health information from such
covered entity or arrangement, or from another business asso-
ciate of such covered entity or arrangement, to the individual
[45 CFR § 160.103].
Covered entity. 1) a health plan; 2) a health-care clearing-
house; 3) a health-care provider who transmits any health
information in electronic form in connection with a transac-
tion [45 CFR § 160.103].
Covered functions. Those functions of a covered entity the
performance of which makes the entity a health plan,
health-care provider, or health-care clearinghouse [45 CFR §
164.103].
Data aggregation. With respect to protected health infor-
mation created or received by a business associate in its capac-
ity as the business associate of a covered entity, the combining
of such protected health information by the business associate
with the protected health information received by the busi-
ness associate in its capacity as a business associate of another
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covered entity, to permit data analyses that relate to the health-
care operations of the respective covered entities [45 CFR
§164.501].
De-identified health information. Health information that
does not identify an individual and with respect to which no
reasonable basis exists to believe that the information can be
used to identify an individual is not individually identifiable
information. [45 CFR § 164.514(a)].
Disclosure. The release, transfer, provision of access to, or
divulging in any other manner of information outside the entity
holding the information [45 CFR § 160.103].
Electronic media. 1) Electronic storage media including
memory devices in computers (hard drives) and any remov-
able/transportable digital memory medium, such as magnetic
tape or disk, optical disk, or digital memory card; or 2) trans-
mission media used to exchange information already in elec-
tronic storage media. Transmission media include, for example,
the Internet (wide open), extranet (using Internet technology
to link a business with information accessible only to collabo-
rating parties), leased lines, dial-up lines, private networks,
and the physical movement of removable/transportable elec-
tronic storage media. Certain transmissions, including of
paper, via facsimile, and of voice, via telephone, are not con-
sidered to be transmissions via electronic media, because the
information being exchanged did not exist in electronic form
before the transmission [45 CFR § 160.103].
Health care. Care, services, or supplies related to the health
of an individual. It includes but is not limited to 1) preven-
tive, diagnostic, therapeutic, rehabilitative, maintenance, or
palliative care, and counseling, service, assessment, or proce-
dure with respect to the physical or mental condition, or func-
tional status, of an individual or that affects the structure or
function of the body; and, 2) sale or dispensing of a drug,
device, equipment, or other item in accordance with a pre-
scription [45 CFR § 160.103].
Health-care clearinghouse. A public or private entity,
including a billing service, repricing company, community
health management information system, community health
information system, or value-added network or switch that 1)
processes or facilitates the processing of health information
received from another entity in a nonstandard format or con-
taining nonstandard data content into standard data elements
or a standard transaction or 2) receives a standard transaction
from another entity and processes or facilitates the processing
of health information into nonstandard format or nonstand-
ard data content for the receiving entity [45 CFR § 160.103].
Health-care operations. Any of the following activities of
the covered entity to the extent that the activities are related to
covered functions: 1) conducting quality assessment and
improvement activities, population-based activities, and
related functions that do not include treatment; 2) reviewing
the competence or qualifications of health care professionals,
evaluating practitioner, provider, and health plan performance,
conducting training programs where students learn to prac-
tice or improve their skills as health-care providers, training of
nonhealth-care professionals, accreditation, certification,
licensing, or credentialing activities; 3) underwriting, premium
rating, and other activities relating to the creation, renewal or
replacement of a contract of health insurance or benefits; 4)
conducting or arranging for medical review, legal services, and
auditing functions, including fraud and abuse detection and
compliance programs; 5) business planning and development,
such as conducting cost-management and planning-related
analyses related to managing and operating the entity, includ-
ing formulary development and administration, development
or improvement of methods of payment or coverage policies;
and 6) business management and general administrative
activities of the entity [45 CFR § 164.501].
Health-care provider. A provider of services, (as defined in
section 1861(u) of the Act, 42 U.S.C. 1395x(u)), a provider
of medical or health-care services, (as defined in section 1861(s)
of the Act, 42 U.S.C. 1395x(s)), and any other individual or
organization that furnishes, bills, or is paid for health care in
the normal course of business [45 CFR § 160.103].
Health information. Any information, whether oral or
recorded in any form or medium, that 1) is created or received
by a health-care provider, health plan, public health authority,
employer, life insurer, school or university, or health-care clear-
inghouse; and 2) relates to the past, present, or future physical
or mental health or condition of an individual, the provision
of health care to an individual, or the past, present, or future
payment for the provision of health care to an individual [45
CFR § 160.103].
Health plan. An individual or group plan that provides, or
pays the cost of, medical care (as defined in section 2791(a)(2)
of the PHS Act, 42 U.S.C. 300gg-91(a)(2)). Health plan
includes the following, singly or in combination: (i) a group
health plan as defined in 45 CFR § 160.103 of the Privacy
Rule; (ii) a health insurance issuer, as defined in 45 CFR §
160.103 of the Privacy Rule; (iii) an HMO, as defined in 45
CFR § 160.103 of the Privacy Rule; (iv) Part A or B of the
Medicare program under title XVIII of the Act; (v) the Med-
icaid program under title XIX of the Act, 42 U.S.C. 1396 et
seq.; (vi) an issuer of a Medicare supplemental policy, (as
defined in section 1882(g)(1) of the Act, 42 U.S.C.
1395ss(g)(1)); (vii) an issuer of a long-term care policy,
excluding a nursing home fixed-indemnity policy; (viii) an
employee welfare benefit plan or any other arrangement that
is established or maintained for the purpose of offering or pro-
viding health benefits to the employees of two or more
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employers; (ix) the health care program for active military per-
sonnel under title 10, U.S.C.; (x) the veterans health-care pro-
gram under 38 U.S.C. Ch. 17; (xi) the Civilian Health and
Medical Program of the Uniformed Services (CHAMPUS)
(as defined in 10 U.S.C. 1072(4)); (xii) the Indian Health
Service program under the Indian Health Care Improvement
Act, 25 U.S.C. 1601, et seq.; (xiii) the Federal Employees
Health Benefits Program under 5 U.S.C. 8902, et seq.; (xiv)
an approved state child health plan under title XXI of the Act,
providing benefits for child health assistance that meet the
requirements of section 2103 of the Act; 42 U.S.C. 1397, et
seq.; (xv) the Medicare+Choice program under Part C of title
XVIII of the Act, 42 U.S.C. 1395w-21 through 1395w-28;
(xvi) a high risk pool that is a mechanism established under
state law to provide health insurance coverage or comparable
coverage to eligible individuals; (xvii) any other individual or
group plan, or combination of individual or group plans, that
provides or pays for the cost of medical care (as defined in
section 2791(a)(2) of the PHS Act, 42 U.S.C. 300gg-91(a)(2))
[45 CFR § 160.103].
The term health plan excludes: (i) any policy, plan, or pro-
gram to the extent that it provides, or pays for the cost of,
excepted benefits that are listed in §2791(c)(1) of the PHS
Act, 42 U.S.C. 300gg-91(c)(1); and, (ii) a government-funded
program, other than the one listed in items (i)-(xvi) above,
whose principal purpose is other than providing, or paying
the cost of, health care, or whose principal activity is 1) the
direct provision of health care to individuals; or 2) the mak-
ing of grants to fund the direct provision of health care to
individuals [45 CFR § 160.103].
Hybrid entity. A single legal entity 1) that is a covered e
ntity; 2) whose business activities include both covered and
noncovered functions; and 3) that designates its health-care
components [45 CFR § 164.103].
Individually identifiable health information. A subset of
health information, including demographic information col-
lected from an individual, and 1) is created or received by a
health-care provider, health plan, employer, or health-care clear-
inghouse; and, 2) relates to the past, present, or future physi-
cal or mental health or condition of an individual, the provision
of health care to an individual, or the past, present, or future
payment for the provision of health care to an individual; and,
that identifies the individual or where there is a reasonable
basis to believe the information can be used to identify the
individual [45 CFR § 164.501].
Limited data set. Protected health information that excludes
certain direct identifiers of the individual or of relatives,
employers, or household members of the individual. Direct
identifiers to be excluded can be found in 45 CFR §
164.514(e)(2).
Minimum necessary. For any type of disclosure that a cov-
ered entity makes on a routine and recurring basis, that the
covered entity must implement policies and procedures (which
may be standard protocols) that limit the protected health
information disclosed to the amount reasonably necessary to
achieve the purpose of the disclosure. For all other disclosures,
covered entities must develop and implement criteria designed
to limit the protected health information disclosed to the
information reasonably necessary to accomplish the purpose
for which disclosure is sought and review requests for disclo-
sure on an individual basis in accordance with such criteria. A
covered entity may rely, if such reliance is reasonable under
the circumstances, on a requested disclosure as the minimum
necessary for the stated purpose when (a) making disclosures
to public officials that are permitted under 45 CFR § 164.512,
if the public official represents that the information requested
is the minimum necessary for the stated purpose, (b) if the
information is requested by another covered entity (c) their
business associates providing personal services, or (d) docu-
mentation or representations that comply with the applicable
requirements of 45 CFR § 164.512(i) have been provided by
an individual requesting the information for research purposes
[45 CFR § 164.514(d)(3)].
The minimum necessary standard also applies to uses of
protected health information [45 CFR § 164.514(d)(2)] and
requests for protected health information [45 CFR §
164.514(d)(4)].
Notice. An individual, with certain exceptions, has a right
to adequate notice of the uses and disclosures of protected
health information that may be made by the covered entity
and of the individual’s rights, and the covered entity’s legal
duties, with respect to protected health information. The
notice must be written in plain language and contain the fol-
lowing elements: (i) a header as specified in the rule; (ii) a
description, including at least one example, of the types of
uses and disclosures that the covered entity is permitted to
make for treatment, payment, and health care operations, and
a description of each of the other purposes for which the cov-
ered entity is permitted or required to use or disclose pro-
tected health information without the individual’s written
consent or authorization. If a use or disclosure is prohibited
or materially limited by other applicable law, the description
of such use or disclosure must reflect the more stringent law
(as defined in 45 CFR § 160.202). Each description must
include sufficient detail to place the individual on notice of
the uses and disclosures that are permitted or required by the
Privacy Rule or other applicable law, and a statement that other
uses and disclosures will be made only with the individual’s
written authorization and that the individual may revoke such
authorization as provided by 45 CFR § 164.508(b)(5).
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A separate statement must be included in the notice if a
covered entity intends to engage in any of the following
activities. The statement should explain that 1) the covered
entity may contact the individual to provide appointment
reminders or information regarding treatment alternatives or
other health-related benefits; 2) the covered entity may con-
tact the individual to raise funds for the covered entity; or 3) a
group health plan, health insurer, or HMO with respect to a
group health plan may disclose protected health information
to the sponsor of the plan.
The notice must contain a statement of the individual’s rights
with respect to the protected health information and a brief
description of how the individual may exercise these rights, a
statement of the covered entity’s duties, a statement that indi-
viduals may complain to the covered entity or the Secretary if
they believe their privacy rights have been violated, contact
information, and the effective date of the notice [45 CFR §
164.520].
Payment. 1) The activities undertaken by (i) a health plan
to obtain premiums or to determine or fulfill its responsibility
for coverage and provision of benefits under the health plan;
or (ii) a health-care provider or health plan to obtain or pro-
vide reimbursement for the provision of health care; and 2)
the activities relate to the individual to whom health care is
provided and include, but are not limited to (i) determina-
tions of eligibility or coverage and adjudication or subroga-
tion of health benefit claims; (ii) risk adjusting amounts due
based on enrollee health status and demographic characteris-
tics; (iii) billing, claims management, collection activities,
obtaining payment under a contract for reinsurance (includ-
ing stop-loss insurance) and related health-care data process-
ing; (iv) review of health-care services with respect to medical
necessity, coverage under a health plan, appropriateness of care,
or justification of charges; (v) utilization review activities,
including precertification and preauthorization of services, con-
current and retrospective review of services; and (vi) disclo-
sure to consumer reporting agencies of any of the following
protected health information relating to collection of premi-
ums or reimbursement: (a) name and address; (b) date of birth;
(c) social security number; (d) payment history; (e) account
number; and (f ) name and address of the health-care provider
or health plan [45 CFR § 164.501].
Protected health information (PHI). Individually identi-
fiable health information that is transmitted by electronic
media, maintained in electronic media, or transmitted or
maintained in any other form or medium. PHI excludes indi-
vidually identifiable health information in: (i) education
records covered by the Family Education Rights and Privacy
Act (20 U.S.C. 1232g); (ii) records described at 20 U.S.C.
1232g(a)(4)(B)(iv); and (iii) employment records held by a
covered entity in its role as employer [45 CFR § 160.103].
Public health authority. An agency or authority of the
United States, a state, a territory, a political subdivision of a
state or territory, or an Indian tribe, or an individual or entity
acting under a grant of authority from or contract with such
public agency, including the employees or agents of such pub-
lic agency or its contractors or individuals or entities to whom
it has granted authority, that is responsible for public health
matters as part of its official mandate [45 CFR § 164.501].
Examples of public health authorities include state and
local health departments, CDC, National Institutes of Health
(NIH), Food and Drug Administration (FDA), and Occupa-
tional Safety and Health Administration (OSHA).
Required by law. A mandate contained in law that compels
an entity to make a use or disclosure of protected health infor-
mation and that is enforceable in a court of law. This term
includes, but is not limited to court orders and court-ordered
warrants; subpoenas or summons issued by a court, grand jury,
a governmental or tribal inspector general, or an administra-
tive body authorized to require the production of informa-
tion; a civil or an authorized investigative demand; Medicare
conditions of participation with respect to health-care provid-
ers participating in the program; and statutes or regulations
that require the production of information, including statutes
or regulations that require such information if payment is
sought under a government program providing public ben-
efits [45 CFR § 164.103].
Research. A systematic investigation, including research
development, testing, and evaluation, designed to develop or
contribute to generalizable knowledge [45 CFR § §164.501].
Statistical de-identification. A properly qualified statisti-
cian using accepted analytical techniques concludes that the
risk is limited that the information could be used, alone or in
combination with other reasonably available information to
identify the subject of the information [45 CFR § 164.514(b)].
Safe harbor method. A covered entity or its agent removes
a comprehensive set of identifiers enumerated in the Privacy
Rule, which includes but is not limited to, names, geographic
subdivisions smaller than states, dates more specific than years,
contact information, identification numbers and photographic
images, and has no actual knowledge that the remaining
information could be used alone or in combination with other
information to identify the individual who is a subject of the
information, or the individual’s relatives, employers, or house-
hold members. Eighteen specific identifiers will need to be
removed to achieve de-identification [45 CFR § 164.514(b)].
Transaction. The transmission of information between two
parties to carry out financial or administrative activities
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related to health care. It includes the following types of infor-
mation transmissions: health care claims or equivalent encoun-
ter information; health care payment and remittance advice;
coordination of benefits; health care claim status; enrollment
and disenrollment in a health plan; eligibility for a health plan;
health plan premium payments; referral certification and
authorization; first report of injury; health claims attachments;
and other transactions that the Secretary may prescribe by regu-
lation [45 CFR § 164.103].
Treatment. The provision, coordination, or management
of health care and related services by one or more health-care
providers, including the coordination or management of health
care by a health-care provider with a third party; consultation
between health-care providers relating to a patient; or the
referral of a patient for health care from one health-care pro-
vider to another [45 CFR § 164.501].
Use. With respect to individually identifiable health infor-
mation, the sharing, employment, application, utilization,
examination, or analysis of such information within an entity
that maintains such information [45 CFR § 160.103].
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Appendix B
Sample Text That Can Be Used To Clarify Public Health Issues
Under the Privacy Rule
pursuant to the Standards for Privacy of Individually Identifi-
able Health Information promulgated under the Health
Insurance Portability and Accountability Act (HIPAA) [45
CFR Parts 160 and 164)]. Under this rule, covered entities
may disclose, without individual authorization, protected
health information to public health authorities “ . . . autho-
rized by law to collect or receive such information for the pur-
pose of preventing or controlling disease, injury, or disability,
including, but not limited to, the reporting of disease, injury,
vital events such as birth or death, and the conduct of public
health surveillance, public health investigations, and public
health interventions . . . .” The definition of a public health au-
thority includes “ . . . an individual or entity acting under a grant
of authority from or contract with such public agency . . . .”
[Authorized agency] is acting under [contract, grant, coop-
erative agreement] with [public health authority] to conduct
[project], which is authorized by [law or regulation]. [Public
health authority] grants this authority to [authorized agency]
for purposes of this project. Further, [public health authority]
considers this to be [activity type], for which disclosure of
protected health information by covered entities is authorized
by 45 CFR § 164.512(b) of the Privacy Rule.
From a public health authority to a covered entity, con-
firming grant of authority to an authorized agency
To Whom It May Concern:
 [Public health authority] is an agency of [parent authority]
and is a public health authority as defined by the Health
Insurance Portability and Accountability Act (HIPAA), Stan-
dards for Privacy of Individually Identifiable Health Informa-
tion; Final Rule (Privacy Rule)[45 CFR § 164.501]. Pursuant
to 45 CFR § 164.512(b) of the Privacy Rule, covered entities
may disclose protected health information to public health
authorities “ . . . authorized by law to collect or receive such
information for the purpose of preventing or controlling dis-
ease, injury, or disability, including, but not limited to, the
reporting of disease, injury, vital events such as birth or death,
and the conduct of public health surveillance, public health
investigations, and public health interventions . . . .” The defi-
nition of public health authority includes “ . . . an individual
or entity acting under a grant of authority from or contract
with such public agency . . .” [45 CFR § 164.501]. [Autho-
rized agency] is acting under [contract, grant or cooperative
agreement] with [public health authority] to carry out [project].
Following are sample letters that can be used to help clarify
Privacy Rule issues among covered entities and public health
authorities (e.g., CDC, National Institutes of Health, Food
and Drug Administration, Substance Abuse and Mental Health
Services Administration, Health Resources and Services
Administration, state and local health departments). Public
health authorities can use these letters as templates by insert-
ing names of the appropriate individuals, projects, agreements,
laws, activity types, covered entities, public health authorities,
and authorized agencies.
From a public health authority to a covered entity, clari-
fying rules regarding disclosure
To Whom it May Concern:
[Public health authority] is an agency of [parent authority]
and is conducting the activity described here in its capacity as
a public health authority as defined by the Health Insurance
Portability and Accountability Act (HIPAA), Standards for
Privacy of Individually Identifiable Health Information; Final
Rule (Privacy Rule) [45 CFR §164.501]. Pursuant to 45 CFR
§164.512(b) of the Privacy Rule, covered entities such as your
organization may disclose, without individual authorization,
protected health information to public health authorities “ . .
. authorized by law to collect or receive such information for
the purpose of preventing or controlling disease, injury, or
disability, including, but not limited to, the reporting of dis-
ease, injury, vital events such as birth or death, and the con-
duct of public health surveillance, public health investigations,
and public health interventions . . . ”
[Public health authority] is conducting [project], a public
health activity as described by 45 CFR § 164.512(b), and is
authorized by [law or regulation]. The information being
requested represents the minimum necessary to carry out the
public health purposes of this project pursuant to 45 CFR
§164.514(d) of the Privacy Rule.
If you have questions or concerns please contact [project
leader].
 From a public health authority to an authorized agency,
providing grant of authority
Dear [authorized agency]:
This letter serves as verification of a grant of authority from
[public health authority] for you to conduct the public health
activities described here, acting as a public health authority
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Through this grant of authority, [authorized agency] may func-
tion as a public health authority under the Privacy Rule for
purposes of this project.
[Project] is a public health activity as described by 45 CFR
§ 164.512(b) referenced previously, and is authorized by [law
or regulation]. The information being requested represents the
minimum necessary to carry out the public health purposes of
this project pursuant to 45 CFR § 164.514(d) of the Privacy
Rule. The Privacy Rule provides that covered entities “ . . .
may rely, if such reliance is reasonable under the circumstances,
on a requested disclosure as the minimum necessary for the
stated purposes when making disclosures to public officials
that are permitted under 45 CFR § 164.512, if the public
official represents that the information requested is the mini-
mum necessary for the stated purposes(s).”
If you have questions or concerns please contact [project
leader for authorized agency; public health authority contact].
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